GT Biopharma Inc. (GTBP) Total Assets by Year
GT Biopharma Inc. closed fiscal year 2025 with $8.1M in total assets, $2.3M in total liabilities and $5.8M in shareholder equity. This represents an increase of 91.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters GT Biopharma Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
GTBP Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.1M+91.5% | $4.2M-70.0% | $14.1M-15.7% | $16.7M-48.0% | $32.2M+468.3% | $5.7M+1329.5% | $396K-98.4% | $25.4M-90.0% | $254.4M+1017372.0% | $25K-53.7% | $54K-93.9% | $888K+504.1% | $147K-35.0% | $226K+75.2% | $129K |
| Total Liabilities | $2.3M-60.7% | $5.9M-11.0% | $6.6M+32.6% | $5.0M-51.2% | $10.3M-70.8% | $35.1M+78.1% | $19.7M+40.5% | $14.0M+423.7% | $2.7M-85.9% | $18.9M-62.6% | $50.6M+66.2% | $30.5M+370.0% | $6.5M-1.2% | $6.6M+25.5% | $5.2M |
| Total Equity | $5.8M+446.5% | -$1.7M-122.3% | $7.5M-36.3% | $11.7M-46.4% | $21.9M+174.4% | -$29.4M-52.4% | -$19.3M-269.8% | $11.4M-95.5% | $251.7M+1430.0% | -$18.9M+62.6% | -$50.6M-71.0% | -$29.6M-366.9% | -$6.3M0.0% | -$6.3M-24.2% | -$5.1M |
GTBP Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q/A | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q/A | Q2'2410-Q/A | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | N/A | $8.1M+91.5% | $4.3M-36.1% | $7.1M-23.1% | N/A | $4.2M-70.0% | $6.8M-58.1% | $9.3M-48.9% | $9.9M-50.7% | $14.1M-15.7% | $16.1M-23.4% |
| Total Liabilities | N/A | N/A | $2.3M-60.7% | $1.3M-71.7% | $33.0M+777.9% | N/A | $5.9M-11.0% | $4.7M-24.1% | $3.8M-41.1% | $4.6M-34.6% | $6.6M+32.6% | $6.1M+20.1% |
| Total Equity | $3.6M+113.8% | $7.6M+873.5% | $5.8M+446.5% | $3.0M+43.1% | -$25.9M-569.8% | -$980K-118.4% | -$1.7M-122.3% | $2.1M-79.0% | $5.5M-53.2% | $5.3M-59.3% | $7.5M-36.3% | $10.0M-37.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More GT Biopharma Inc. financials
Frequently Asked Questions
What was GT Biopharma Inc.'s total assets in fiscal year 2025?
GT Biopharma Inc. closed fiscal year 2025 with $8.1M in total assets, $2.3M in total liabilities and $5.8M in shareholder equity.
How fast is GT Biopharma Inc.'s total assets growing?
GT Biopharma Inc. (GTBP) total assets rose by 91.5% year over year, from $4.2M to $8.1M in fiscal year 2025.
How has GT Biopharma Inc.'s total assets changed over the years?
Across the 15 fiscal years this page covers, GT Biopharma Inc. (GTBP) total assets went from $129K in fiscal year 2011 to $8.1M in fiscal year 2025.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what GT Biopharma Inc. (GTBP) reported on that line in every period on record.